{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:29:21Z","timestamp":1786984161704,"version":"build-2736575974"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Polish Ministry of Science and Higher Education"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.advms.2019.02.003","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T13:50:15Z","timestamp":1551707415000},"page":"258-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["IL-1\u03b1 and IL-6 predict vascular events or death in patients with cerebral small vessel disease\u2014Data from the SHEF-CSVD study"],"prefix":"10.1016","volume":"64","author":[{"given":"Jacek","family":"Staszewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Skrobowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5127-9652","authenticated-orcid":false,"given":"Renata","family":"Piusi\u0144ska-Macoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Brodacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"St\u0119pie\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.advms.2019.02.003_bib0005","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","article-title":"Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges","volume":"9","author":"Pantoni","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.advms.2019.02.003_bib0010","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1474-4422(13)70060-7","article-title":"Mechanisms underlying sporadic cerebral small vessel disease: insights from neuroimaging","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.advms.2019.02.003_bib0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/jcbfm.2015.116","article-title":"Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: a review","volume":"36","author":"Poggesi","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.advms.2019.02.003_bib0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.advms.2019.02.003_bib0025","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1001\/jama.285.19.2481","article-title":"Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease","volume":"285","author":"Ridker","year":"2001","journal-title":"JAMA"},{"issue":"29","key":"10.1016\/j.advms.2019.02.003_bib0030","article-title":"Causes and consequences of cerebral small vesseldisease. The RUN DMC study: a prospective cohort study. Study rationale and protocol","volume":"11","author":"van Norden","year":"2011","journal-title":"BMC Neurol"},{"key":"10.1016\/j.advms.2019.02.003_bib0035","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"The SPS3 Study Group. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial","volume":"382","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.advms.2019.02.003_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2017.e00455","article-title":"Risk of vascular events in different manifestations of cerebral small vessel disease: a 2-year follow-up study with a control group","volume":"3","author":"Staszewski","year":"2017","journal-title":"Heliyon"},{"key":"10.1016\/j.advms.2019.02.003_bib0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000438494","article-title":"Plasma biomarkers of inflammation, endothelial function and hemostasis in cerebral small vessel disease","volume":"40","author":"Wiseman","year":"2015","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.advms.2019.02.003_bib0050","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1212\/WNL.0000000000001279","article-title":"Inflammatory biomarkers, cerebral microbleeds, and small vessel disease: Framingham Heart Study","volume":"84","author":"Shoamanesh","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.advms.2019.02.003_bib0055","article-title":"Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome","volume":"15","author":"Smith","year":"2004","journal-title":"BMC Neurol"},{"key":"10.1016\/j.advms.2019.02.003_bib0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000074791","article-title":"Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice","volume":"17","author":"Castillo","year":"2004","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.advms.2019.02.003_bib0065","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","article-title":"Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNF alpha, and INF gamma concentrations are elevated in patients with atypical and idiopathic parkinsonism","volume":"22","author":"Brodacki","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.advms.2019.02.003_bib0070","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/hh2401.101272","article-title":"CD40 signaling and plaque instability","volume":"89","author":"Sch\u00f6nbeck","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.advms.2019.02.003_bib0075","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/01.STR.0000154878.58398.14","article-title":"Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis","volume":"36","author":"Novo","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2019.02.003_bib0080","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pjnns.2017.11.005","article-title":"Association between hemostatic markers, serum lipid fractions and progression of cerebral small vessel disease: a 2-year follow-up study","volume":"52","author":"Staszewski","year":"2018","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.advms.2019.02.003_bib0085","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/424695","article-title":"Significance of haemodynamic and haemostatic factors in the course of different manifestations of cerebral small vessel disease: the SHEF-CSVD study\u2014study rationale and protocol","volume":"2013","author":"Staszewski","year":"2013","journal-title":"Neurosci J"},{"key":"10.1016\/j.advms.2019.02.003_bib0090","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mds.20083","article-title":"Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis","volume":"19","author":"Zijlmans","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.advms.2019.02.003_bib0095","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1212\/WNL.42.3.473","article-title":"Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer\u2019s Disease Diagnostic and Treatment Centers","volume":"42","author":"Chui","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.advms.2019.02.003_bib0100","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mds.20083","article-title":"Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis","volume":"19","author":"Zijlmans","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.advms.2019.02.003_bib0105","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.advms.2019.02.003_bib0110","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging","volume":"149","author":"Fazekas","year":"1987","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.advms.2019.02.003_bib0115","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1212\/WNL.0000000000000837","article-title":"Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden","volume":"30","author":"Staals","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.advms.2019.02.003_bib0120","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1161\/01.STR.18.3.545","article-title":"The natural history of lacunar infarction: the Oxfordshire Community Stroke Project","volume":"18","author":"Bamford","year":"1987","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2019.02.003_bib0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000047700","article-title":"Survival and recurrent strokes in patients with different subtypes of stroke: a 14-year follow-up study","volume":"12","author":"Eriksson","year":"2001","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.advms.2019.02.003_bib0130","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1212\/01.wnl.0000210457.89798.0e","article-title":"A population-based study of the incidence and prognosis of lacunar stroke","volume":"66","author":"Sacco","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.advms.2019.02.003_bib0135","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1474-4422(03)00352-1","article-title":"Long-term prognosis after lacunar infarction","volume":"2","author":"Norrving","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.advms.2019.02.003_bib0140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/str.33.1.297","article-title":"Twenty-four-hour blood pressure and MRI as predictive factors for different outcomes in patients with lacunar infarct","volume":"33","author":"Yamamoto","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2019.02.003_bib0145","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/STROKEAHA.114.005018","article-title":"Lacunar trokes in patients with diabetes mellitus: risk factors, infarct location, and prognosis: the secondary prevention of small subcortical strokes study","volume":"45","author":"Palacio","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2019.02.003_bib0150","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000098054","article-title":"Brain lesions on MRI in elderly patients with type 2 diabetes mellitus","volume":"57","author":"van Harten","year":"2007","journal-title":"Eur Neurol"},{"key":"10.1016\/j.advms.2019.02.003_bib0155","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/01.STR.27.8.1274","article-title":"Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study","volume":"27","author":"Longstreth","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2019.02.003_bib0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/ane.12398","article-title":"Is type 2 diabetes related to leukoaraiosis? An updated review","volume":"132","author":"Del Bene","year":"2015","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.advms.2019.02.003_bib0165","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/01.STR.0000053843.03997.35","article-title":"Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes","volume":"34","author":"Laing","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2019.02.003_bib0170","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2337\/dc06-2363","article-title":"Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes","volume":"30","author":"Janghorbani","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.advms.2019.02.003_bib0175","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000100980","article-title":"Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: a comparative study","volume":"23","author":"Brands","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.advms.2019.02.003_bib0180","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/archneur.57.4.507","article-title":"Parkinson disease survival: a population-based study","volume":"57","author":"Morgante","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.advms.2019.02.003_bib0185","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.parkreldis.2016.08.010","article-title":"Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls","volume":"32","author":"Fielding","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.advms.2019.02.003_bib0190","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.parkreldis.2016.08.010","article-title":"Medium-term prognosis of an incident cohort of parkinsonian patients compared to controls","volume":"32","author":"Fielding","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.advms.2019.02.003_bib0195","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/hs1201.100209","article-title":"Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study","volume":"32","author":"Kolominsky-Rabas","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2019.02.003_bib0200","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/brain\/awh636","article-title":"Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction","volume":"128","author":"Jackson","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.advms.2019.02.003_bib0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/JAD-150925","article-title":"Evaluation of underlying causes of death in patients with dementia to support targeted advance care planning","volume":"53","author":"van de Vorst","year":"2016","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.advms.2019.02.003_bib0210","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1468-1331.2008.02503.x","article-title":"Cause of death in patients with dementia disorders","volume":"16","author":"Brunnstr\u00f6m","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.advms.2019.02.003_bib0215","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/STROKEAHA.115.012166","article-title":"Inflammatory markers and outcomes after lacunar stroke: the Levels of Inflammatory Markers in Treatment of Stroke Study","volume":"47","author":"Boehme","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2019.02.003_bib0220","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/01.STR.0000154878.58398.14","article-title":"Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis","volume":"36","author":"Novo","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2019.02.003_bib0225","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000196823","article-title":"Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke","volume":"27","author":"Welsh","year":"2009","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.advms.2019.02.003_bib0230","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/hs1101.098151","article-title":"Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham Study","volume":"32","author":"Rost","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2019.02.003_bib0235","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/ATVBAHA.112.301174","article-title":"Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community","volume":"33","author":"Schnabel","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.advms.2019.02.003_bib0240","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.advms.2019.02.003_bib0245","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1212\/WNL.0b013e3181bd10bc","article-title":"High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study","volume":"20","author":"Elkind","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.advms.2019.02.003_bib0250","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/STROKEAHA.113.004562","article-title":"C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke study","volume":"45","author":"Elkind","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2019.02.003_bib0255","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/hs0402.105339","article-title":"Inflammation-mediated damage in progressing lacunar infarctions: a potnential therapeutic target","volume":"33","author":"Castellanos","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2019.02.003_bib0260","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000196823","article-title":"Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke","volume":"27","author":"Welsh","year":"2009","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.advms.2019.02.003_bib0265","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/STROKEAHA.106.474569","article-title":"Predictive variables for mortality after acute ischemic stroke","volume":"38","author":"Carter","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2019.02.003_bib0270","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1161\/STROKEAHA.114.005592","article-title":"Population-based study of blood biomarkers in prediction of sub-acute recurrent stroke","volume":"45","author":"Segal","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2019.02.003_bib0275","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-2125.2012.04212.x","article-title":"Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review","volume":"74","author":"Hasan","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.advms.2019.02.003_bib0280","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/iub.1377","article-title":"Interleukin-1a and Brain Inflammation","volume":"67","author":"Brough","year":"2015","journal-title":"IUBMB Life"},{"key":"10.1016\/j.advms.2019.02.003_bib0285","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.jacc.2013.12.030","article-title":"Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a)","volume":"63","author":"Tsimikas","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.advms.2019.02.003_bib0290","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1161\/STROKEAHA.115.008685","article-title":"Soluble CD40L is a useful marker to predict future strokes in patients with minor stroke and transient ischemic attack","volume":"46","author":"Li","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2019.02.003_bib0295","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.STR.0000169924.60783.d4","article-title":"Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities: longitudinal results of Austrian Stroke Prevention Study","volume":"36","author":"Markus","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2019.02.003_bib0300","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1212\/WNL.0b013e3182407968","article-title":"Neuropathologic evidence of endothelial changes in cerebral small vessel disease","volume":"78","author":"Giwa","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.advms.2019.02.003_bib0305","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/jnnp.72.5.576","article-title":"Significance of white matter high intensity lesions as a predictor of stroke from arteriolosclerosis","volume":"72","author":"Yamauchi","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.advms.2019.02.003_bib0310","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/WNL.0b013e3181a18823","article-title":"Severity of leukoaraiosis correlates with clinical outcome after ischemic stroke","volume":"72","author":"Arsava","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.advms.2019.02.003_bib0315","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1212\/WNL.0b013e318248e50f","article-title":"Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study","volume":"78","author":"Satizabal","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.advms.2019.02.003_bib0320","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/01.WCB.0000100044.07481.97","article-title":"Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke","volume":"23","author":"Montaner","year":"2003","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.advms.2019.02.003_bib0325","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1161\/01.STR.0000058480.77236.B3","article-title":"Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?","volume":"34","author":"Wardlaw","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.advms.2019.02.003_bib0330","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0022-510X(97)00137-8","article-title":"Risk factors for microangiopathy-related cerebral damage in the Austrian Stroke Prevention Study","volume":"152","author":"Schmidt","year":"1997","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.advms.2019.02.003_bib0335","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000066161","article-title":"Fibrinogen and the amount of leukoaraiosis in patients with symptomatic small-vessel disease","volume":"48","author":"Marti-Fabregas","year":"2002","journal-title":"Eur Neurol"},{"key":"10.1016\/j.advms.2019.02.003_bib0340","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/STROKEAHA.113.004059","article-title":"Circulating inflammatory markers are associated with magnetic resonance imaging-visible perivascular spaces but not directly with white matter hyperintensities","volume":"45","author":"Aribisala","year":"2014","journal-title":"Stroke"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S189611261830169X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S189611261830169X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:41:49Z","timestamp":1761824509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S189611261830169X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S189611261830169X"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2019.02.003","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-1\u03b1 and IL-6 predict vascular events or death in patients with cerebral small vessel disease\u2014Data from the SHEF-CSVD study","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2019.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}